Inhibition of aldosterone synthase: Does this offer advantages compared with the blockade of mineralocorticoid receptors?

Hypertens Res. 2023 Apr;46(4):1056-1057. doi: 10.1038/s41440-023-01188-z. Epub 2023 Jan 18.
No abstract available

Keywords: Aldosterone synthase inhibitor; Baxdrostat; Mineralocorticoid receptor antagonist; Renin-angiotensin-aldosterone system.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aldosterone*
  • Cytochrome P-450 CYP11B2
  • Double-Blind Method
  • Healthy Volunteers
  • Humans
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Receptors, Mineralocorticoid* / metabolism
  • Renin-Angiotensin System / drug effects

Substances

  • Aldosterone
  • Receptors, Mineralocorticoid
  • Cytochrome P-450 CYP11B2
  • Mineralocorticoid Receptor Antagonists